121 related articles for article (PubMed ID: 31399174)
1. Financial Burden of Liver Transplant vs Resection for Hepatocellular Carcinoma.
Skill NJ; Butler J; O'Brien DC; Kays JK; Kubal CA; Liangpunsakul S; Ninad N; Maluccio MA
Transplant Proc; 2019; 51(6):1907-1912. PubMed ID: 31399174
[TBL] [Abstract][Full Text] [Related]
2. Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.
Shaya FT; Breunig IM; Seal B; Mullins CD; Chirikov VV; Hanna N
Pharmacoeconomics; 2014 Jan; 32(1):63-74. PubMed ID: 24293197
[TBL] [Abstract][Full Text] [Related]
3. Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?
Landman MP; Feurer ID; Pinson CW; Moore DE
HPB (Oxford); 2011 Nov; 13(11):783-91. PubMed ID: 21999591
[TBL] [Abstract][Full Text] [Related]
4. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.
Tapper EB; Catana AM; Sethi N; Mansuri D; Sethi S; Vong A; Afdhal NH
Cancer; 2016 Mar; 122(6):852-8. PubMed ID: 26716758
[TBL] [Abstract][Full Text] [Related]
5. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K;
Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349
[TBL] [Abstract][Full Text] [Related]
6. Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.
Vitale A; Farinati F; Burra P; Trevisani F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Missale G; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Chiaramonte M; Spolverato G; Cillo U;
Liver Transpl; 2015 Oct; 21(10):1250-8. PubMed ID: 26183802
[TBL] [Abstract][Full Text] [Related]
7. Health care costs associated with hepatocellular carcinoma: a population-based study.
Thein HH; Isaranuwatchai W; Campitelli MA; Feld JJ; Yoshida E; Sherman M; Hoch JS; Peacock S; Krahn MD; Earle CC
Hepatology; 2013 Oct; 58(4):1375-84. PubMed ID: 23300063
[TBL] [Abstract][Full Text] [Related]
8. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective.
Sarasin FP; Giostra E; Mentha G; Hadengue A
Hepatology; 1998 Aug; 28(2):436-42. PubMed ID: 9696009
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria.
Lim KC; Wang VW; Siddiqui FJ; Shi L; Chan ES; Oh HC; Tan SB; Chow PK
Hepatology; 2015 Jan; 61(1):227-37. PubMed ID: 24638991
[TBL] [Abstract][Full Text] [Related]
10. Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.
Lim C; Compagnon P; Sebagh M; Salloum C; Calderaro J; Luciani A; Pascal G; Laurent A; Levesque E; Maggi U; Feray C; Cherqui D; Castaing D; Azoulay D
HPB (Oxford); 2015 Jul; 17(7):611-23. PubMed ID: 25980326
[TBL] [Abstract][Full Text] [Related]
11. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.
Vitale A; Cucchetti A; Qiao GL; Cescon M; Li J; Ramirez Morales R; Frigo AC; Xia Y; Tuci F; Shen F; Cillo U; Pinna AD
J Hepatol; 2014 Jun; 60(6):1165-71. PubMed ID: 24508550
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of whole-body bone scans in the pre-liver transplant assessment of patients with hepatocellular carcinoma in Southern Brazil.
Rodríguez S; Balbinotto Neto G; Kiss G; Brandão A;
Clin Transplant; 2016 Apr; 30(4):399-406. PubMed ID: 26783162
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
Patel D; Terrault NA; Yao FY; Bass NM; Ladabaum U
Clin Gastroenterol Hepatol; 2005 Jan; 3(1):75-84. PubMed ID: 15645408
[TBL] [Abstract][Full Text] [Related]
14. Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling.
Cannon RM; Scoggins CR; Callender GG; Quillo A; McMasters KM; Martin RC
Ann Surg Oncol; 2013 Sep; 20(9):2887-92. PubMed ID: 23636514
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.
Llovet JM; Mas X; Aponte JJ; Fuster J; Navasa M; Christensen E; Rodés J; Bruix J
Gut; 2002 Jan; 50(1):123-8. PubMed ID: 11772979
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis.
Gournay J; Tchuenbou J; Richou C; Masliah C; Lerat F; Dupas B; Martin T; Nouel JF; Schnée M; Montigny P; D'Alincourt A; Hamy A; Paineau J; Le Néel JC; Le Borgne J; Galmiche JP
Aliment Pharmacol Ther; 2002 Aug; 16(8):1529-38. PubMed ID: 12182753
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
19. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
[TBL] [Abstract][Full Text] [Related]
20. Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent.
Muaddi H; Al-Adra DP; Beecroft R; Ghanekar A; Moulton CA; Doyle A; Selzner M; Wei A; McGilvray ID; Gallinger S; Grant DR; Cattral MS; Greig PD; Kachura J; Cleary SP; Sapisochin G
Ann Surg Oncol; 2018 Apr; 25(4):991-999. PubMed ID: 29327179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
